Upregulated UBE2C expression was significantly correlated with poor prognosis and Overall survival (OS) of patients with ACC, BRCA, KIRC, KIRP, Low grade glioma (LGG), LUAD, MESO, PAAD, and Skin cutaneous melanoma (SKCM) (Figure 3A). Here, UBE2C is linked to pancreatic adenocarcinoma.